Your browser doesn't support javascript.
loading
Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma.
Zheng, Hongyan; Guo, Xiaorong; Li, Nan; Qin, Luyao; Li, Xiaoqing; Lou, Ge.
Afiliação
  • Zheng H; Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Guo X; Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li N; Department of Pathology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Qin L; Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Li X; Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Lou G; Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Front Genet ; 13: 922401, 2022.
Article em En | MEDLINE | ID: mdl-36159998
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article